Skip to main content

Table 3 Expression levels of biomarkers CEA (ng/ml), CA125 (U/ml), CYFRA 21-1 (ng/ml), and NY-ESO-1 (MFI) for LC cases and matched controls in the training (n=230) and validation (n=150) data sets

From: Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer

Biomaker

Statistic

cancer_train

cancer_valid

control_train

control_valid

CA125

N

115.00

75.00

115.00

75.00

 

Mean

16.76

42.18

9.55

8.47

 

StdDev

18.85

135.95

7.71

7.29

 

Min

2.19

3.56

0.00

0.00

 

Max

170.10

1181.4

41.77

54.96

CEA

N

115.00

75.00

115.00

75.00

 

Mean

6.81

9.60

1.35

1.41

 

StdDev

13.87

18.01

0.85

1.03

 

Min

0.34

0.25

0.04

0.00

 

Max

93.37

71.35

6.28

5.96

CYFRA 21-1

N

115.00

75.00

115.00

75.00

 

Mean

15.58

4.60

5.93

1.93

 

StdDev

55.49

4.34

9.67

1.73

 

Min

0.00

0.00

0.00

0.00

 

Max

553.85

21.88

89.09

7.17

NY-ESO-1

N

115.00

75.00

115.00

75.00

 

Mean

158.17

133.00

49.76

55.68

 

StdDev

442.34

290.50

71.12

63.24

 

Min

3.37

4.00

3.33

0.00

 

Max

3298.3

1890.8

417.70

420.33